US2023212234A1PendingUtilityA1

Silk Protein Fragment Compositions and Articles Manufactured Therefrom

Assignee: EVOLVED BY NATURE INCPriority: Sep 30, 2013Filed: Jul 11, 2022Published: Jul 6, 2023
Est. expirySep 30, 2033(~7.2 yrs left)· nominal 20-yr term from priority
A61K 47/12A61K 31/375A61K 47/36A61K 38/1767A61K 31/728A61K 31/19A61K 45/06A61K 31/191A61K 47/02A61K 31/194A61K 8/73A61K 8/67A61K 38/01A61K 8/92A61K 8/30A61K 8/20C07K 14/43586A61K 8/64A61K 8/02A61K 8/19A61K 8/365A61K 8/676A61K 8/735A61K 8/922A61K 8/97A61K 9/08A61Q 17/04A61Q 19/00A61Q 19/02A61Q 19/08C07K 1/12A61K 8/042A61K 2800/72A61K 38/00A61K 38/012A61K 8/0216A61Q 19/007A61K 8/9789A61K 8/9794A61P 17/00A61P 17/16A61K 2800/74A61K 8/29A61K 2800/591A61K 8/4953A61K 8/27A61K 8/987A61K 2800/75A45D 33/00
85
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition is disclosed that includes pure silk fibroin-based protein fragments that are substantially devoid of sericin, wherein the composition has an average weight average molecular weight ranging from about 17 kDa to about 38 kDa, wherein the composition has a polydispersity of between about 1.5 and about 3.0, wherein the composition is substantially homogeneous, wherein the composition between 0 ppm to about 500 ppm of inorganic residuals, and wherein the composition includes between 0 ppm to about 500 ppm of organic residuals.

Claims

exact text as granted — not AI-modified
1 - 45 . (canceled) 
     
     
         46 . A composition comprising:
 silk fibroin protein fragments having an average weight average molecular weight selected from between about 17 kDa to about 38 kDa, and a polydispersity of between about 1.5 and about 3.0;   0 to 500 ppm of inorganic residuals; and   0 to 500 ppm of organic residuals,   wherein the composition does not spontaneously or gradually gelate and does not visibly change in color or turbidity when in an aqueous solution for at least 10 days.   
     
     
         47 . The composition of  claim 46 , wherein the silk fibroin protein fragments comprise about 0.01% (w/w) to about 10% (w/w) sericin. 
     
     
         48 . The composition of  claim 46 , wherein the composition is substantially homogeneous. 
     
     
         49 . An aqueous solution comprising the composition of  claim 46 . 
     
     
         50 . A serum comprising the composition of  claim 46 . 
     
     
         51 . The serum of  claim 50 , comprising from about 0.1 wt. % to about 6.0 wt. % of silk fibroin protein fragments. 
     
     
         52 . The serum of  claim 50 , further comprising an additive selected from the group consisting of vitamin E, rosemary oil, rose oil, lemon juice, lemon grass oil, vanilla, geranium, and green tea. 
     
     
         53 . The serum of  claim 50 , further comprising from about 0.5 wt. % to about 30.0 wt. % of vitamin C or a derivative thereof. 
     
     
         54 . A film comprising the composition of  claim 46 . 
     
     
         55 . The film of  claim 54 , wherein the film is sufficiently flexible to conform to anatomical topographies. 
     
     
         56 . The film of  claim 54 , wherein the silk fibroin protein fragments comprise between about 1.0% and about 50.0% crystalline protein domains. 
     
     
         57 . The film of  claim 54 , comprising from about 30.0 wt. % to about 99.5 wt. % of silk fibroin protein fragments. 
     
     
         58 . The film of  claim 54 , further comprising from about 1.0 wt. % to about 50.0 wt. % of vitamin C or a derivative thereof. 
     
     
         59 . The film of  claim 54 , further comprising one or more therapeutic agents, growth factors, antioxidants, proteins, carbohydrates, polymers, nucleic acids, salts, acids, bases, biomolecules, glycosamino glycans, polysaccharides, extracellular matrix molecules, metals, metal ion, metal oxide, synthetic molecules, polyanhydrides, cells, fatty acids, fragrance, minerals, plants, plant extracts, preservatives, and essential oils. 
     
     
         60 . The film of  claim 54 , further comprising an alpha hydroxy acid selected from glycolic acid, lactic acid, tartaric acid, and citric acid. 
     
     
         61 . The film of  claim 54 , further comprising hyaluronic acid or its salt form at a concentration ranging from about 0.5 wt. % to about 10.0 wt. %. 
     
     
         62 . The film of  claim 54 , further comprising at least one of zinc oxide or titanium dioxide.

Join the waitlist — get patent alerts

Track US2023212234A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.